Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482337 · ClinicalTrials.gov registry record · NA
Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02482337 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 42 participants.
The verdict
NCT02482337, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to show that the Per-Oral Endoscopic Myotomy (POEM) procedure is an effective treatment for people with achalasia.
Interventions
- PROCEDURE POEM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-06 |
| Est. Completion | 2024-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02482337
The ClinicalTrials.gov registry entry for NCT02482337 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which POEM is the first listed.
NCT02482337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02482337 about?
NCT02482337 is a clinical study titled "Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders". The purpose of this study is to show that the Per-Oral Endoscopic Myotomy (POEM) procedure is an effective treatment for people with achalasia.
What is the current status of trial NCT02482337?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2014-06. Estimated completion is 2024-10.
What interventions are being tested in trial NCT02482337?
The interventions under investigation include: POEM (PROCEDURE).
Who is sponsoring clinical trial NCT02482337?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.